Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Serie:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Ämnen:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Länkar:https://www.rpcardio.com/jour/article/view/1769
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk